Insider Transactions in Q1 2022 at Mannkind Corp (MNKD)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Jennifer Grancio |
BUY
Open market or private purchase
|
Direct |
110,701
+31.14%
|
$221,402
$2.71 P/Share
|
|
Feb 28
2022
|
Michael Castagna Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,675
+1.77%
|
$55,350
$2.71 P/Share
|
|
Feb 28
2022
|
Stuart A Tross Chief People & Workpl Officer |
BUY
Open market or private purchase
|
Direct |
9,225
+1.44%
|
$18,450
$2.71 P/Share
|
|
Feb 28
2022
|
Christine Mundkur |
BUY
Open market or private purchase
|
Direct |
27,675
+9.81%
|
$55,350
$2.71 P/Share
|
|
Feb 28
2022
|
Anthony C Hooper |
BUY
Open market or private purchase
|
Direct |
40,000
+10.57%
|
$80,000
$2.71 P/Share
|
|
Feb 28
2022
|
Alejandro Galindo EVP Endocrine Business Unit |
BUY
Open market or private purchase
|
Direct |
36,900
+6.01%
|
$73,800
$2.71 P/Share
|
|
Jan 31
2022
|
Michael Castagna Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,334
+0.15%
|
$7,002
$3.17 P/Share
|
|
Jan 31
2022
|
Stuart A Tross Chief People & Workpl Officer |
BUY
Open market or private purchase
|
Direct |
4,254
+0.68%
|
$12,762
$3.17 P/Share
|
|
Jan 31
2022
|
Alejandro Galindo EVP Endocrine Business Unit |
BUY
Open market or private purchase
|
Direct |
2,334
+0.43%
|
$7,002
$3.17 P/Share
|
|
Jan 31
2022
|
Steven B. Binder EVP Special Projects |
BUY
Open market or private purchase
|
Direct |
711
+0.13%
|
$2,133
$3.17 P/Share
|